The 7th edition of the Global Health Forum, held at the Riyadh International Convention & Exhibition Center, witnessed significant announcements from leading healthcare companies regarding major investments aimed at transforming the healthcare infrastructure in Saudi Arabia. These investments support Saudi Vision 2030 by enhancing healthcare services, increasing capacity, and fostering innovation in the medical sector.
🔸️ Dallah Health announced a strategic investment of SAR 4 billion ($1.07 billion) in the healthcare sector in Riyadh, which will boost the group’s assets by 45%, reaching a total of SAR 13 billion ($3.47 billion) by 2028. This expansion is aimed at meeting the growing demand for healthcare services in the Kingdom.
🔸️ Fakieh Healthcare Group revealed plans to invest SAR 5 billion ($1.33 billion) in several expansion projects, including a new hospital in Madinah with a capacity of 200 beds and 49 clinics, another hospital in Makkah as part of the Masar Destination project with 200 beds and 80 clinics, and a hospital in South Obhur, Jeddah, with 300 beds and 100 clinics. The expansion includes a surgical tower at Dr. Soliman Fakeeh Hospital in Jeddah, as well as new medical centers in key cities like Riyadh, Makkah, and Jeddah.
🔸️ Dr Sulaiman AlHabib Medical Centers Group announced an investment of SAR 10 billion ($2.67 billion) to develop and operate 7 hospitals and numerous healthcare facilities. Recent openings include Al Sahafa Hospital, Al Fiha Hospital in Jeddah, and the Women’s Health Hospital. The group’s expansion will increase bed capacity by 2,000 beds, bringing the total to over 4,000 beds, while creating 13,000 job opportunities for Saudi nationals. Additionally, they launched Dr. Sulaiman Al Habib Knowledge Company to oversee medical and academic programs and established the Dr. Sulaiman Al Habib Nursing College in Riyadh, with plans to expand to the Western and Eastern regions.
🔸️ Al Mousa Medical Group announced investments of over SAR 3 billion ($800 million), including the construction of a 400-bed hospital in Al Khobar and a 300-bed hospital in Al Ahsa, along with the establishment of five primary care centers.
🔸️ National Unified Procurement Company “NUPCO” signed a SAR 4 billion ($1.07 billion) pharmaceutical manufacturing deal with Novo Nordisk and Sanofi, and a SAR 3 billion ($800 million) agreement was reached between SEHA Holding and Boston Oncology to localize facilities compliant with Good Manufacturing Practices (GMP).
Finally, a memorandum of understanding (MoU) was signed between the Ministry Investment, the Ministry of Health, and Virtus Health Partners for the Jabal Al Noor University Medical City project in Al Baha, with an investment of SAR 7 billion ($1.87 billion).
